Nevertheless, neither serum CEA level nor the performance of adjuvant treatment (radiation and chemotherapy) were included as predictors, which are widely considered independent prognostic factors for CRC patients [13]. This evidence concerns the gene CEACAM5 and colorectal carcinoma.